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*Author for correspondenceThe formation of the mitotic spindle is an essential pre-
requisite for successful mitosis. The dramatic changes in
the level of microtubule (Mt) nucleation at the centrosomes
and Mt dynamics that occur in prophase are presumed to
be initiated through the activity of cdc2/cyclin B. Here we
present data that the cdc25B isoform functions to activate
the cytoplasmic pool of cdc2/cyclin B responsible for these
events. In contrast to cdc25C, cdc25B is present at low
levels in HeLa cells during interphase, but sharply
increases in prophase, when cdc25B accumulation in the
cytoplasm correlates with prophase spindle formation.
Overexpression of wild type and dominant negative
mutants of cdc25B and cdc25C shows that prophase Mt
nucleation is a consequence of cytoplasmic cdc25B activity,
and that cdc25C regulates nuclear G2/M events. Our data
also suggest that the functional status of the centrosome can
regulate nuclear mitotic events. 
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SUMMARYINTRODUCTION
A major regulator of entry into mitosis is the cdc2 gene
product. Its role is highly conserved, homologues of this gene
having been identified in organisms as widely divergent as
yeast, mammals and plants (Nurse and Bisset, 1981; Lee and
Nurse, 1987; Feiler and Jacobs, 1990). It functions through its
protein kinase activity to regulate a vast array of cellular
protein substrates, some of which produce the dramatic
cytoskeletal and structural rearrangements observed at mitosis.
In yeast, the cdc2 gene product regulates both entry into the
cell cycle or START and progression into mitosis (Nurse and
Bisset, 1981). In vertebrates these functions are carried out by
distinct members of a highly homologous family of proteins
known as cyclin dependent kinases (cdk). Cdc2 is the proto-
typic cdk and retains its central role in regulating entry into
mitosis in mammalian cells (Hamaguchi et al., 1992; van den
Heuvel and Harlow, 1993). 
The activity of cdc2 is itself regulated in a complex manner.
The cdc2 monomer is catalytically inactive and requires the
association of a regulatory cyclin subunit for activity. In ver-
tebrate systems, cyclin B is synthesised during S and G2 phases
and immediately complexes with cdc2 in the cytoplasm. The
kinase complex is maintained in an inactive form until the
G2/M transition through the inhibitory phosphorylations of the
threonine 14 and tyrosine 15 residues of cdc2 (Krek and Nigg,
1991a,b; Norbury et al., 1991). In fission yeast only tyrosine
15 is phosphorylated by the wee1 gene product (Featherstoneand Russell, 1991; Parker et al., 1991). In higher eukaryotes,
a wee1-like activity has been identified which phosphorylates
both threonine 14 and tyrosine 15 in vitro (Atherton-Fessler et
al., 1994). 
The inactive cdc2/cyclin B complex is activated in late
prophase by the cdc25 gene product. The cdc25 gene product
acts as a dual specificity phosphatase and can dephosphorylate
both the threonine 14 and tyrosine 15 residues of the inactive
cdc2/cyclin B complex to yield an active protein kinase
(Dunphy and Kumagai, 1991; Gautier et al., 1991; Strausfeld
et al., 1991; Lee et al., 1992; Gabrielli et al., 1992; Sebastian
et al., 1993). In fission yeast only a single isoform of this
protein has been identified (Russell and Nurse, 1986),
however, human cells contain three isoforms, A, B and C
(Sadhu et al., 1990; Galaktionov and Beach, 1991; Nagata et
al., 1991). The mammalian cdc25C has been demonstrated to
be an important regulator of entry into mitosis (Millar et al.,
1991; Seki et al., 1992), and the mammalian cdc25A isoform
appears to regulate the G1/S phase transition (Jinno et al., 1994;
Hoffmann et al., 1994) where it presumably activates the
tyrosine phosphorylated cdk2/cyclin E complex. The
remaining mammalian cdc25 isoform, cdc25B has so far been
little studied. 
Among the most striking changes at mitosis are the
cytoskeletal rearrangements. These rearrangements are
regulated by the centrosome, but the nature of this regulation
is poorly understood. At mitosis, each centrosome acts as the
microtubule organising centre (MTOC) for the mitotic spindle,
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trosomes increases up to 5-fold that of the interphase centro-
some (Kuriyama and Borisy, 1981). The Mt dynamics also
change dramatically, from long, slow growing interphase Mt
to shorter, more rapidly turning over mitotic Mt. Both the
increased Mt nucleation and changes in the Mt dynamics have
been shown to be under the control of cdc2/cyclin B, although
the direct targets of this kinase in this function are unclear
(Verde et al., 1990, 1992; Masuda et al., 1992; Ohta et al.,
1993). Cdc2 and cyclin B both accumulate at the centrosome
during interphase (Riabowol et al., 1989; Bailly et al., 1989,
1992 ; Pines and Hunter, 1991; Gallant and Nigg, 1992), sug-
gesting that the localised kinase functions to phosphorylate the
centrosomal targets. Therefore the regulation of the
cdc2/cyclin B kinase complex at the centrosome is of central
importance for the proper functioning of the centrosome at
mitosis. 
In this study we have investigated the expression and
function of the cdc25B isoform. Using antibodies specific for
cdc25B, we demonstrate that cdc25B is expressed in late G2
and metaphase in HeLa cells, that this expression is cytoplas-
mic and that it correlates with increased Mt nucleation on the
centrosomes. By overexpressing catalytically inactive mutants
we have demonstrated that cdc25B is a regulator of the G2/M
transition, and that this is distinct from the cdc25C regulatory
function at G2/M. Finally, we present evidence that cdc25B
regulates the Mt nucleating activity of mitotic centrosomes and
the dynamics of the Mt arrays at prophase. 
MATERIALS AND METHODS 
Construction of the GST-cdc25B and N-terminal cdc25B
plasmids
We independently isolated a 3 kb cDNA encoding a 79 bp 5¢ UTR,
full length cdc25B ORF and 3¢ UTR, which was subcloned at the
EcoRI site of pBluescript KS(+) (Stratagene) to yield cdc25B/KS(+).
The insert was orientated such that the cdc25B 5¢ UTR was proximal
to the polylinker’s BamHI site. The major difference between our
cDNA and the published sequence was a 42 bp insert also found in
the mouse and rat cdc25B sequences (Nagata et al., 1991; Jinno et al.,
1994; I. D. Tonks et al., unpublished data). The 5 ¢ UTR and first 354
bp of the cdc25B ORF was isolated from cdc25B/KS(+) as a distinct
469 bp BstXI fragment which was then partially digested with BanI
to remove the entire 5¢ UTR and first 6 bp of the ORF. The resultant
348 bp BanI/BstXI product was end filled with dNTPs using the
Klenow fragment of DNA polymerase I and subcloned at the SmaI
site of pBluescript KS(+) such that the 5¢ end of the insert was
proximal to the polylinker’s BamHI site. The full length cDNA minus
the 5¢ UTR and first 6 bp of the ORF was obtained by subcloning the
2.7 kb BstEII/HindIII fragment from cdc25B/KS(+) at the corre-
sponding sites of the plasmid containing the 348 bp BanI/BstXI
fragment of cdc25B. To produce a GST-fusion protein of the full
length cdc25B, the 5¢ UTR truncated clone was completely digested
with BamHI and DraI, a 3.94 kb fragment isolated and subjected to
partial EcoRI digestion. The resultant 2.9 kb BamHI/EcoRI fragment
was subcloned in the correct reading frame, at the corresponding sites
of pGEX-2T (Pharmacia). This expressed a GST-fusion of cdc25B
from the third amino acid onwards.
To produce the GST-N-terminal cdc25B fusion, the 5.8 kb
BsrGI/EcoRI fragment of the pGEX-2T-cdc25B plasmid was end
filled with dNTPs using the Klenow fragment of DNA polymerase I
and self ligated. This expressed a GST-fusion of the N-terminal 311
amino acids of cdc25B. Expression constructs and mutants
To transiently overexpress cdc25B in HeLa cells, the 3 kb XhoI/XbaI
fragment from cdc25B/KS(+) was subcloned into the corresponding
sites of both pSVK3 (Pharmacia) and pUCSRa (Takebe et al., 1988)
mammalian expression vectors to yield pSVK3 cdc25B and pUCSRa
cdc25B. Dominant negative mutants of cdc25B were produced by
mutating the essential catalytic Cys487 and Arg493 residues of the
cdc25B/KS(+) construct using the USE mutagenesis kit (Pharmacia)
based on the unique site elimination strategy of Deng and Nickoloff
(1992). The mutant oligonucleotide primers used eliminated a unique
BamHI site in the Bluescript plasmid and introduced a BglII site (KS
Bam/Bgl) while mutations were introduced into the cdc25B as
described above along with a silent mutation of the EcoRI site imme-
diately downstream of the Cys codon. Two mutants were produced
with either the single Cys to Ser mutation or the double Cys to Ser
and Arg to Lys (25B C/S and 25B CR/SK, respectively). The oligonu-
cleotides used were:
KS Bam/Bgl: 5 ¢ CT CTC TAG AAC TAG TAG ATC TTC CGG GCT
GC 3¢ ;
25B C/S: 5¢ CCT CAT TTT CCA CAG TGA GTT CTC ATC TGA
GCG TGG GCC CCG C 3¢ ;
25B CR/SK: 5¢ CCT CAT TTT CCA CAG TGA GTT CTC ATC TGA
GAA AGG GCC CCG C 3 ¢ .
The mutations are underlined. The mutations were introduced into
pGEX cdc25B by subcloning the 0.7 kb AvrII-ApaI fragment from
the appropriate cdc25B/KS(+) mutant into the corresponding sites in
pGEX cdc25B. The mutant versions of cdc25B were subcloned into
pUCSR a as a XhoI-XbaI full length cDNA from the mutant
cdc25B/KS(+). 
Dominant negative versions of cdc25C were produced by mutation
of the catalytic Cys377 and Arg383 in pML25 (Lee et al., 1992). The
oligonucleotides used in the USE strategy mutated the unique EcoRV
site in pGEX and introduced an NdeI site (pGEX RV/Nde), and
mutated the catalytic Cys and Arg, and the unique EcoRI site 3¢ to
the Cys codon as described for cdc25B (25C C/S and 25C CR/SK).
The mutations are underlined:
pGEX RV/Nde: 5 ¢ GCG TTG GTG CGC ATA TGT CGG TAG TGG
G 3¢ ;
25C C/S: 5¢ CCA CTC TGA GTT CTC CTC AGA GAG GGG CCC
CCG 3 ¢ ;
25C CR/SK: 5¢ CCA CTC TGA GTT CTC CTC AGA GAA GGG
CCC CCG 3 ¢ .
The wild type and mutant cdc25C were subcloned into pUCSR a
by digesting pML25 with BamHI and subcloning the resultant 1.8 kb
fragment into the corresponding site in pUCSRa . 
Bacterial expression and protein purification
The GST-cdc25B and GST-cdc25C fusion protein expression was
carried out in E. coli DH5 a cells transformed with the appropriate
pGEX-2T cdc25 construct by induction with 0.5 mM IPTG for 3-4
hours at 37°C. The cell pellet was freeze/thawed and lysed using the
Sarkosyl method of Frangioni and Neel (1993). Human cyclin B1 was
expressed as a GST-fusion from a recombinant baculovirus in Sf9
cells (Parker et al., 1991). To affinity purify GST-fusion proteins,
lysate was diluted in 2-4 volumes of NETN (20 mM Tris-HCl, pH
8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP40) buffer containing
protease inhibitors (1 mM PMSF, 5 m g/ml aprotinin, 5 m g/ml pepstatin
A and 5 m g/ml leupeptin) and mixed with glutathione agarose (GTA)
beads (Sigma) for 40 minutes at 4°C. The GTA beads were then
washed three times in NETN at 4°C, once in PBS containing 2 mM
ATP for 30 minutes at 25°C, then twice in NETN containing 1 M
NaCl followed by an additional wash in NETN. The GST-fusion
proteins were eluted twice with the addition of an equal volume of 50
mM sodium borate, pH 8.2, 0.1% SDS and recovered by acetone pre-
cipitation (Frangioni and Neel, 1993). Precipitated protein was redis-
solved in the same borate buffer and either loaded onto preparative
10% SDS-PAGE for immunogen preparation or coupled to activated
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the antibodies produced.
p-Nitrophenyl phosphatase assays
GST fusions of cdc25B and cdc25C expressed in bacteria were
purified on GTA beads and eluted in NETN containing 10 mM glu-
tathione and 2 mM DTT, pH 8.5, for 1 hour at 4°C. The activity of
the eluted proteins was assayed by adding 25 m l of 0.5 M p-nitro-
phenyl phosphate to 225 m l of eluted GST-cdc25 (3 m g of GST-
cdc25B and 4 m g of the GST-cdc25C) and incubating for 1 hour at
30°C. The reaction was stopped by the addition of 250 m l of 0.5 M
NaOH and the p-nitrophenol produced was quantitated by its
absorbance at 410 nm. The wild type and mutants of each cdc25 were
treated in an identical fashion.
Antibody preparation and immunoblotting 
Polyclonal rabbit antisera were raised against purified, bacterially
expressed human full length cdc25B, cdc25C and Sf9 expressed cyclin
B1 GST-fusion proteins, obtained as described above. Purified GST-
fusion proteins were separated using SDS-PAGE and bands visualised
by briefly staining with Coomassie Blue. Gel slices of the appropri-
ately sized fusion protein were excised and used as the immunogen.
GST-reactive antibodies were depleted from the crude sera using a
GST-Sepharose affinity column prior to affinity purification using
either the GST-cdc25B N-terminal fusion, GST-cdc25C or GST-
cyclin B1 affinity columns for the respective antibodies. The eluted
antibodies were concentrated by precipitation in 50% ammonium
sulphate followed by dialysis into 50 mM Tris-HCl, pH 8.0, contain-
ing 0.5 M NaCl. The mouse monoclonal anti- a -tubulin antibody was
purchased from Amersham. For immunoblotting, proteins were elec-
trotransferred to nitrocellulose membrane, blocked with 5% Blotto
(non fat skim milk in PBS containing 0.05% Tween-20). The
membranes were probed overnight at 4°C with a 1/100 dilution of the
affinity purified cdc25B antibodies, or 1/1,000 dilutions of the affinity
purified cdc25C and cyclin B1 antibodies diluted in 1% Blotto. Blots
were developed using horseradish peroxidase conjugated secondary
antibodies and the ECL detection system (Du Pont NEN). For the
cdc25B antibody, incubation with secondary antibody and all washes
were performed at 4°C. 
To demonstrate specificity of staining primary antibodies were
incubated for 1 hour at room temperature in the presence of the appro-
priate GST-fusion protein linked to GTA beads. The GTA beads were
removed by centrifugation and supernatants used for immunoblotting
or cell staining (see below).
HeLa cell culture and synchrony
HeLa cells were grown in 5% FBS/RPMI 1640. Cells were synchro-
nised by a double thymidine block/release as described by Atherton-
Fessler et al. (1994). At each time point cells were fixed with 70%
ethanol at - 20°C and stained with propidium iodide (50 m g/ml) for
FACS analysis of their DNA content. The remainder of the cells were
lysed in NETN/0.4 M NaCl in the presence of protease inhibitors (as
used for bacterial lysates), and the supernatants used for either anti-
cyclin B1 immunoprecipitate H1 kinase assays (Atherton-Fesseler et
al., 1994) or separated on 10% SDS-PAGE and immunoblotted. To
prepare cytoplasmic and nuclear fractions, 2· 106 cells were incubated
in 0.4 ml lysis buffer (5 mM Tris-HCl, pH 7.4, 150 mM sucrose, 50
mM NaCl, 2 mM DTT, 5 mM KCl, 0.5 mM CaCl2, 1 mM MgCl2, 0.1
% NP-40) with protease inhibitors as for the other lysis buffers above,
for 5 minutes at 4°C then passed through a 26 gauge needle repeatedly
to remove residual cytoplasm from the nuclei. The integrity of the
nuclei was monitored by observation using phase contrast microscopy.
The nuclear pellet was collected by centrifugation at 500 g for 2
minutes and solubilised by boiling in 0.4 ml of SDS sample buffer. 
In vitro 35S-labelling and immunoprecipitation
In vitro transcription and translation of cdc25B off the pSVK3 cdc25Bconstruct using T7 polymerase was carried out in rabbit reticulocyte
lysate (Promega) and labelled with 50 m Ci 35S Met (NEN) in 50 m l
for 1 hour at 37°C. The lysates were diluted to 400 m l with NETN
and protease inhibitors then precleared with 50 m l of a 50% suspen-
sion of Protein A-Sepharose (Pharmacia). The supernatants were then
incubated with either preimmune or 0.5 m g affinity purified cdc25B
N-terminal antibody for 2 hours at 4°C followed by a further hour
after adding 40 m l of a 50% suspension of Protein A-Sepharose. The
immunoprecipitates were washed three times with RIPA buffer, then
twice with NETN containing 1 M NaCl and finally with PBS, prior
to analysis on 10% SDS-PAGE. 
Transient transfection in HeLa cells and FACS analysis
The wild type and mutant cdc25s were expressed in HeLa cells by
transient transfection of the pUCSRa versions of the appropriate
cDNA. 107 cells were transfected with 20 m g plasmid by electropo-
ration in 10% FCS/RPMI 1640. Cell samples were collected at several
time points after transfection, fixed with 70% ethanol at - 20°C
overnight and then incubated with either anti-N-terminal cdc25B
(1/50 dilution) or anti-cdc25C (1/250 dilution) antibodies in TBS con-
taining 0.1% skim milk powder for 1 hour. The cell pellets were then
stained with anti-rabbit FITC-labelled secondary antibody (1/20
dilution; Amersham) and 50 m g/ml propidium iodide, 1 mg/ml RNase
A. The DNA content of the transfected cells was analysed by FACS,
gating for cells expressing the transfected cdc25 at levels >20% above
the peak mitotic levels in cells transfected with the control vector;
2,000-10,000 overexpressing cells were counted in each experiment.
The percentage of cells in G1, S and G2/M phases was simply deter-
mined by partitioning the DNA histogram based on the G1 and G2/M
peaks from control transfections performed in each experiment. In
some experiments, transfected cells were also seeded onto glass cov-
erslips, fixed at the indicated time after transfection and then analysed
by indirect immunofluorescence microscopy.
Immunofluorescence microscopy
Both transfected and non-transfected HeLa cells were grown on glass
coverslips for immunofluorescence microscopy. Cells were washed in
PHEM buffer (45 mM Pipes + 45 mM Hepes, pH6.9, 10 mM EGTA,
5 mM MgCl2 containing 1 mM PMSF) prior to rapid fixation in
methanol at - 20°C for 6 minutes (Bailly et al., 1992). Coverslips were
affixed to slides and air dried before being rehydrated in TBS con-
taining 0.1% skim milk powder. Primary antibodies were incubated
on the coverslips overnight at 4°C in PBS containing 0.1% Tween-20
and 3% BSA at the following dilutions; a -tubulin, 1/1,000; N-
terminal cdc25B, 1/25 for untransfected cells or 1/100 for transfected
cells; cdc25C, 1/200 for untransfected cells or 1/500 for transfected
cells; cyclin B, 1/500. The secondary antibodies were either TRITC-
labelled anti-mouse Ig (1/50; Sigma) or FITC-labelled anti-mouse Ig
(1/20; Amersham) or FITC-labelled anti-rabbit Ig (1/20; Amersham).
DNA staining was carried out with 2.5 m g/ml propidium iodide
(Sigma) or 0.05 m g/ml Hoechst 33342 (Calbiochem-Behring Corp.).
Immunofluorescent preparations were mounted in Vectashield
mounting medium (Vector Laboratories). All figures were pho-
tographed with a Zeiss Plan Apochromat oil immersion objective
(· 100) or a Ziess Plan-Neoflu oil immersion objective (· 100) using
EPL-400 Kodak film. 
RESULTS
To investigate the function of the cdc25B isoform in HeLa
cells, we produced polyclonal antibodies against the bacteri-
ally expressed GST-fusion product of cdc25B. The antiserum
was initially depleted of antibodies directed against the GST
moiety and the cdc25B directed antibodies were affinity
purified against GST-fusion product of the N-terminal
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antibody specific for cdc25B, as the three human cdc25
isoforms have a high degree of sequence identity in their
catalytic C-terminal domains (Galaktionov and Beach, 1991).
The affinity purified N-terminal cdc25B antibody displayed no
cross-reactivity to bacterially expressed GST nor to a truncated
GST-C-terminal cdc25B fusion protein, but detected both the
GST-N-terminal and GST-cdc25B full length proteins (Fig.
1A). This N-terminal cdc25B antibody showed no crossreac-
tivity with bacterially expressed GST-cdc25C, and did not
detect bands of between 55 and 65 kDa in HeLa cell lysates,
corresponding to the cdc25A and cdc25C isoforms (Fig. 1B).
The unmodified full length cdc25B expressed in bacteria wasalso specifically detected by the antibody, but a similar size
band was difficult to detect in immunoblots of asynchronous
HeLa cell lysates. A slightly higher molecular mass band of 85
kDa was clearly evident in HeLa cells synchronised with a
double thymidine block and then allowed to progress to G2/M
(Fig. 1B). The antibody also specifically immunoprecipitated
the 85 kDa cdc25B from 35S Met-labelled, in vitro translation
of the cdc25B cDNA (Fig. 1C). 
Cell cycle dependent expression of cdc25B
The inability to detect cdc25B in asynchronous HeLa cells, and
its relative abundance in synchronised G2/M HeLa cells,
suggested that the protein may be expressed in a cell cycle
dependent manner. Immunoblotting of lysates prepared from
equivalent numbers of HeLa cells progressing synchronously
from G1/S following release from a double thymidine block,
showed that the expression of cdc25B protein rapidly increased
in late G2 (9 hours after release from the thymidine block)
immediately prior to the activation of the major pool of
cdc2/cyclin B (Fig. 2A and B). The level of cdc25B protein
increased in metaphase (10 hours after release) where it
resolved into a doublet, with the slower migrating form
probably representing a phosphorylated form. The protein was
then rapidly degraded with only a low level detectable by 12
hours, when the majority of cells had progressed into the next
G1. In some experiments, very low levels of the faster
migrating form were detected in the other phases of the cell
cycle. The expression of cdc25B is reminiscent of cyclin B,
although the accumulation of cdc25B protein appeared to be
more abrupt than that seen for cyclin B1 (Fig. 2C), and strongly
suggested a mitotic function for cdc25B. 
cdc25B accumulates in the cytoplasm in a cell cycle
dependent manner
The cellular localisation of cdc25B was investigated by
preparing cytoplasmic and nuclear fractions of G2/M phase
cells from a double thymidine synchrony. The late G2 phase
expression of cdc25B was almost exclusively in the cytoplas-Fig. 1. cdc25B is expressed in HeLa cells. (A) Bacterially expressed
GST or GST fusions of the C-terminal (GT-C), N-terminal (GT-N)
or the full length cdc25B (GT-25B) were purified using GTA then
resolved on SDS-PAGE. The gel was then stained with Coomassie
Blue R 250 (Protein) or transferred to a nitrocellulose membrane and
immunoblotted with the cdc25B antibody affinity purified against the
N-terminal GST fusion protein (N-Term.). Antibody binding was
detected using an alkaline phosphatase conjugated secondary
antibody and staining. (B) Crude lysate of bacterially expressed full
length cdc25B (bac.; 20 m g protein) or whole HeLa cell lysates (60
m g protein) of either asynchronous (AS) or synchronised cells
harvested at G2/M (G2/M), were immunoblotted with antibody
affinity purified using the N-terminal cdc25B GST fusion (N-Term.).
To demonstrate the specificity of detection, the antibody was blocked
by preincubation with the GST fusion protein (N-Term. blocked).
The strongly staining band migrating just ahead of the bacterially
expressed cdc25B is due to non-specific staining. (C) 35S-labelled
cdc25B was immunoprecipitated from in vitro translated cdc25B.
Immunoprecipitations were performed using either preimmune IgG
fraction (PI) or antibodies affinity purified against either the N-
terminal (N-term.) or full length cdc25B (cdc25B). The positions of
the molecular mass standards are shown. 
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Fig. 2. Cell cycle specific expression of cdc25B in HeLa cells. HeLa
cells synchronised by a double thymidine block were released and
samples taken at the indicated times. (A) Samples were analysed by
FACS and the percentage of cells in G1 (squares), S phase
(diamonds) and G2/M (circles) quantitated. The histone H1 kinase
activity in cyclin B1 immunoprecipitates was also quantitated (solid
triangles). (B) Whole cell lysates (60 m g protein) of the indicated
time points from the same experiment as in (A) were immunoblotted
with cdc25B N-terminal antibody. (C) Aliquots of the same samples
as in B (10 m g protein) were immunoblotted with cyclin B1 antibody. 
Fig. 3. Cdc25B is expressed in the cytoplasm. Cytoplasmic (Cyto.)
and nuclear (Nuc.) fractions were prepared from cells in G2/M phase
at 10 hours after release from a double thymidine block
synchronisation. Fractions were immunoblotted with the indicated
affinity purified antibodies. 
Fig. 4. Immunofluorescent localisation of cdc25B in untransfected
HeLa cells. (A) N-terminal cdc25B antibody staining of HeLa cells
showing the cytoplasmic accumulation of cdc25B correlates with
prophase Mt nucleation, shown in B with a -tubulin staining of the
same cells. Preincubation of the antibody with the cdc25B N-
terminal GST fusion protein abolished the staining in cells displaying
the same level of Mt nucleation (D and E). (C and F) Hoechst 33342
staining shows the DNA of the same cells. Exposure times for A and
D were identical. Bar, 10 m m. mic fraction (Fig. 3). Cdc25C was found in both the nuclear
and cytoplasmic fractions, as was cyclin B1, reflecting the
translocation of this latter protein from the cytoplasm to the
nucleus just prior to entry into mitosis (Fig. 3; Pines and
Hunter, 1991; Bailly et al., 1992). The presence of cdc25C in
the cytoplasmic fraction was surprising, but this result was
obtained using a number of different mild lysis conditions, sug-
gesting that the normally nuclear HeLa cdc25C was not tightly
associated with nuclear structures and easily extracted,
whereas cyclin A which associates with the chromatin was
found predominantly in the nuclear fraction (Chambers and
Langan, 1990; data not shown). Cdc25B was found to be
almost exclusively cytoplasmic under all lysis conditions
tested. 
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localisation of cdc25B by indirect immunofluorescent
staining of HeLa cells. Only a low level of granular, intranu-
clear staining was observed in interphase cells (Fig. 4A),
which was specifically blocked by preincubating the
antibody with the GST-cdc25B N-terminal fusion protein
(Fig. 4D). However, a small number of cells also displayed
either a perinuclear or more evenly distributed cytoplasmic
staining of the cdc25B protein (Figs 4A and 5A). These cells
with cytoplasmic staining of cdc25B were in prophase, as
the duplicated centrosomes have begun migration to their
mitotic poles, and displayed increased levels of Mt nucle-
ation at the centrosomes and intact nuclei (Kochanski and
Borisy, 1990; Fig. 4B and C). Cytoplasmic staining in these
prophase cells was higher than those of the surrounding
interphase cells and these levels remained high through
metaphase, decreasing in anaphase and telophase back to
interphase levels (Fig. 5A). The rapid increase in prophase
and subsequent decrease in anaphase of cdc25B protein
levels is in agreement with the immunoblotting data (Fig.
2B). Both the cytoplasmic and nuclear staining were
abolished by prior incubation of the antibody with recombi-
nant N-terminal cdc25B (Fig. 4D). Fig. 5. Conversion from interphase to
prophase Mt organisation at the
centrosome correlates with the
accumulation of cdc25B in the
cytoplasm of prophase cells while
cdc25C is retained within the
nucleus. Untransfected HeLa cells
were stained with N-terminal cdc25B
(A), cdc25C (B) and a -tubulin (Mt; C
and D) antibodies. (A) Cdc25B levels
increase at prophase (p) and peak at
metaphase (m; two metaphase cells
displaying mitotic spindles) before
decreasing in anaphase (a) and
telophase (t) to the interphase levels
of the surrounding cells.
Accumulation of cdc25B in the
cytoplasm is evident in the prophase
cells (p and insert) whereas the
interphase cells (unlabelled) display
only weak nuclear staining. (C) a -
Tubulin staining of the same cells as
in A indicates that Mt nucleation has
commenced at the centrosomes of the
prophase cells (p and insert).
Separation of duplicated centrosomes
in the prophase cells is also evident.
(B) Cells showing only nuclear
cdc25C even though the centrosomes
of the prophase cell (centre field)
clearly display prophase Mt
nucleation (D). Bar, 10 m m. Inspection of the cell doubly stained for cdc25B and tubulin
revealed that cells with only background staining for cdc25B
had a basket-like Mt organisation surrounding their nucleus,
consistent with that of interphase cells (Figs 4A and B, 5A).
However, when cells which had a perinuclear or cytoplasmic
accumulation of cdc25B were examined, prophase Mt nucle-
ating activity at the centrosome was found in every case.
Likewise, when cells were identified on the basis of having
prophase Mt nucleation and an intact nuclear membrane,
cdc25B was always observed to be cytoplasmically localised,
establishing a strong correlation between the cytoplasmic accu-
mulation of cdc25B and the conversion of the interphase to
mitotic centrosome. 
Indirect immunofluorescent staining with a human cdc25C
antibody revealed a strong granular staining in intact nuclei
throughout the cell cycle, as reported previously (Millar et al.,
1991). Further, cdc25C remained localised to the nucleus when
prophase Mt nucleation was clearly evident (Fig. 5B). This is
in contrast to the perinuclear and cytoplasmic localisation of
cdc25B at this point in the cell cycle. 
cdc25B functions as a G2/M regulator
The restricted expression of the cdc25B protein to the late
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G2/M transition. To investigate the function of cdc25B
directly we have attempted to produce a dominant negative
mutant of cdc25B by mutating the essential catalytic Cys and
Arg residues in cdc25B (Gautier et al., 1991), and transiently
overexpressing either the wild-type or the mutant proteins in
HeLa cells. Assay of bacterially expressed GST fusions of
the wild-type and mutant cdc25B proteins for their ability to
dephosphorylate p-nitrophenyl phosphate confirmed that
both a Cys to Ser (C/S) mutation and a Cys to Ser, Arg to
Lys double mutation (CR/SK) resulted in catalytically
inactive proteins (Fig. 6A). HeLa cells were transiently
transfected with either wild-type or mutant cdc25B, then
analysed at 24 and 48 hours post transfection. The cells were
stained for cdc25B, and the cell cycle status of overexpress-
ing cells analysed by gating for high FITC fluorescence
intensity (for cdc25B) and assessing their DNA content
(propidium iodide staining) by FACS. Both wild-type and
mutant proteins were strongly overexpressed, although the
full length wild-type cdc25B accumulated to lower levels
than the mutants (Fig. 6B). The lower molecular mass
proteins detected are presumably proteolytic breakdown
products of the overexpressed cdc25B as similar size
fragments were often detected in the bacterially expressed
cdc25B proteins (Fig. 1A). Overexpression of either cdc25B
mutant resulted in an accumulation of the G2/M population
of cells with a concomitant decrease in the G1 population at
24 and 48 hours post transfection compared to the control
vector transfections (Fig. 6C and D). Little change was
observed in the percentage of cells in S phase. The accumu-
lation of cells in G2/M phase could be seen as early as 10
hours post transfection, and increased by 24 hours post trans-
fection (Fig. 6C) reaching a maximum of 50-60% by 48
hours (Fig. 6D; Table 1). The CR/SK double mutant
produced a slightly greater increase in the G2/M population
than the C/S mutant although both mutants were catalytically
inactive. The declining proportion of G1 cells and accumu-
lation of G2/M cells indicates either a delay in transit through
G2 and M phases, or cell cycle arrest in G2 or M. 
An increase in the percentage of cells in S and G2/M phases
was observed with wild type cdc25B overexpression (Table 1).
Unlike the mutants, however, the accumulation was not
prominent until 48 hours post transfection, although a small
effect was evident as early as 24 hours post transfection (Fig.Fig. 6. Overexpression of wild type and mutant cdc25B in HeLa
cells. (A) Bacterially expressed GST or the GST fusions of cdc25B
and mutant cdc25B were assayed for their activity towards p-
nitrophenyl phosphate. The data are the mean ± s.d. of triplicate
determinations. (B) Equal numbers of cells transfected with either
the control vector (con), wild-type cdc25B (WT), or the mutants
(C/S, CR/SK), were immunoblotted for cdc25B 24 hours post
transfection. The full length protein is indicated (arrowhead).
(C) Control vector, wild-type cdc25B or catalytically inactive
mutants in the pUCSRa expression plasmid were transiently
overexpressed in HeLa cells and the cell cycle status of the
overexpressing cells were analysed by FACS. The DNA histograms
from cells harvested 24 hours post transfection are shown. (D) In a
similar experiment to that in C, the DNA histogram from cells
harvested 48 hours post transfection are shown. 
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Table 1. The dominant negative effect of overexpressing
mutants of cdc25B 
Mutant cdc25B 
Cell cycle Control Wild-type
phase vector cdc25B C/S CR/SK 
G1 52±1.8 33±3.6 24±4.5 22±1.3 
S 26±2.7 32±3.1 25±3.7 22±3 
G2/M 22±1 34±0.6 48±6.4 51±2.5
The percentage of cells in each phase of the cell cycle was quantitated by
FACS analysis of the overexpressing cells 48 hours post transfection. The
data represents the mean ± s.d. of three separate experiments. 
Table 2. Transfection of HeLa cells with mutant cdc25B
results in a loss of prophase Mt nucleation when mutant
cdc25B is overexpressed in the cytoplasm
Level of Mt nucleation
Cells
Experiment counted 0 ± + 
1 26 14 11 1 
2 13 5 7 1 
Total 39 19 18 2 
HeLa cells were transfected with mutant cdc25B (CR/SK) in a pUCSRa
vector and seeded onto coverslips. Cells were examined 48 hours post
transfection by indirect immunofluorescence using antibodies to the N-
terminal region of cdc25B and a -tubulin. Cells with a higher level of
overexpressed mutant cdc25B in the cytoplasm than the nucleus (e.g. Fig. 8A
and C) were counted and the level of Mt nucleation in these cells was
evaluated as follows:  0, an interphase basket-like arrangement of Mt (e.g.
Fig.  8B);  ±, intermediate Mt arrangement i.e. Mt gathering at the
centrosome but with no focus of nucleation (e.g. Fig. 8D and insert);  +, weak
Mt nucleation i.e. some centrosomal focus of Mt. 6C and D), perhaps simply reflecting the lower level of accu-
mulation of the wild type at 24 hours post transfection. 
The cdc25C isoform has also been assigned a function in
regulating the G2/M transition so it was necessary to test
whether the cdc25B mutants were producing a specific effect
in competing out the normal cdc25B activity, or whether it
was simply the effect of overexpression of a catalytically
inactive cdc25. To this end, catalytically inactive mutants of
cdc25C similar to those of cdc25B, were produced (Fig. 7A).
FACS analysis of wild-type cdc25C overexpressed in HeLa
cells at 48 hours post transfection showed that in contrast to
overexpression of wild-type cdc25B, overexpression of wild-
type cdc25C had little effect on cell cycle distribution, with
only a small increase in the G2/M population (Fig. 7C)
compared with the strong accumulation in S and G2/M phases
seen with wild-type cdc25B (Fig. 6D). The cdc25C (both
wild type and mutants) was overexpressed greater than 10-
fold at this time (Fig. 7B). The cdc25C mutants produced a
G2/M arrest, but to a lesser degree than that seen with the
cdc25B mutants at 48 hours post transfection (40% compared
to 50-60% for cdc25B), although this increased to 60% by 72
hours post transfection. This effect differed from that
observed with overexpression of the cdc25B mutants in that
it was not evident at 24 hours post transfection (data not
shown), at which stage the cdc25B mutants had already
produced a significant accumulation of G2/M cells (Fig. 6C).
As seen with the cdc25B mutants, the cdc25C CR/SK mutant
produced a more marked G2/M accumulation than the C/S
mutant. 
Cytoplasmic expression of cdc25B regulates
prophase spindle assembly
We have shown that the normal cell cycle dependent
expression of endogenous cdc25B in the cytoplasm prior toTable 3. Overexpression of wild type or mutant cdc25C
Wild type transfected cells
Transfection Nucleators % Nuc
Experiment rate counted transf
1 41% 53 4
2 51% 33 4
3 31% 29 3
HeLa cells were transiently transfected with wild-type or mutant cdc25C (CR/S
hours post transfection by indirect immunofluorescence using antibodies to cdc25
was determined by microscopic examination. Cells with intact nuclear membrane
nucleators (e.g. Fig. 9B and D, arrows). The percentage of nucleators that were trnuclear envelope breakdown correlated with increased Mt
nucleation at the centrosome and prophase spindle formation.
Overexpressed cdc25B (both wild type and mutant) was found
in the cytoplasm in all cases, but in cells heavily overexpress-
ing cdc25B (the majority of transfectants) strong nuclear
staining was also observed (Fig. 8a and c). The nuclear accu-
mulation was unexpected, but was also observed with cdc25B
transfection into neonatal fibroblasts and COS cells, and was,
therefore, not an artefact of overexpression of this protein in
HeLa cells (unpublished results). 
Overexpression of inactive double mutant cdc25B has a
dominant negative effect on prophase microtubule
nucleation
Examination of the Mt staining patterns of cells heavily over-
expressing mutant cdc25B revealed predominantly interphase
Mt networks (Fig. 8D), with very few mitotic spindles
observed even though FACS data showed >50% of these cells
to be in G2 phase (Fig. 6D; Table 1). Detailed examination
of the low level overexpressing cells which displayed
increased cdc25B staining in the perinuclear region or the
cytoplasm but little nuclear staining, also revealed an almost
complete absence of normal prophase Mt nucleation or
mitotic spindle formation, although in many cases they
possessed centrosomes which had migrated to the mitotic
poles (Fig. 8B and D; data not shown). This effect was
observed for both C/S and CR/SK mutants. The low level in HeLa cells does not affect prophase Mt nucleation
Mutant transfected cells 
leators Transfection Nucleators % Nucleators
ected rate counted transfected 
0 33% 50 44
9 27% 31 39
1 26% 12 25
K) in a pUCSRa vector and seeded onto coverslips. Cells were examined at 48
C and a -tubulin. The overall percentage of cells transfected in each experiment
s and centrosomes displaying prophase Mt nucleation were defined as
ansfected was determined by microscopic examination. 
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Fig. 7. Overexpression of wild type and mutant cdc25C in HeLa
cells. (A) Bacterially expressed GST and GST fusions of cdc25C and
mutants were assayed for their activity towards the substrate p-
nitrophenyl phosphate. The data are the mean ± s.d. of triplicate
determinations. (B) Equal numbers of cells transfected with the
control vector (con), wild-type cdc25C (WT), or the mutants (C/S,
CR/SK), were immunoblotted for cdc25C 48 hours post transfection.
The level of endogenous cdc25C is faintly visible in the control lane.
(C) In a similar experiment to Fig. 6c, HeLa cells were transiently
transfected with either control vector, wild type or mutant cdc25C in
the pUCSRa expression plasmid and their cell cycle status analysed
by FACS at 48 hours post transfection. CR/SK expressing cells 48 hours post transfection were quan-
tified for loss of mitotic spindle formation, as this mutant
produced a stronger G2/M accumulation (Fig. 6D). Of the 39
cdc25B CR/SK mutant overexpressing cells which displayed
low level cytoplasmic cdc25B staining, half showed normal
interphase Mt organisation, denoted as ‘0’ nucleation (Table
2; Fig. 8A and B). An almost equal number displayed an area
of Mt concentration in the cytoplasm adjacent to the nucleus
although no focus of Mt nucleation was apparent (Table 2,‘+/-’ nucleation; Fig. 8C and D and insert). In only 2 of the
39 cells counted, a low degree of Mt nucleation and focus
formation (although still less than observed normally) was
detected (Table 2, ‘+’ nucleation). Interestingly, no chromo-
some condensation or nuclear envelope breakdown was
observed in the cells where the overexpressed mutant cdc25B
blocked the cytoplasmic Mt nucleation at the centrosomes.
The almost total absence of Mt nucleation and prophase
spindle formation observed in any of the mutant cdc25B
overexpressors is consistent with the G2 accumulation
observed with FACS analysis, as these mutant expressing
cells are unable to undergo cytokinesis and thus accumulate
with a G2 complement of DNA. 
Overexpression of wild-type cdc25B causes the
formation of abnormal ‘mini-spindles’
Cells overexpressing wild-type cdc25B in the cytoplasm often
displayed bizarre ‘mini-spindles’ which were located to one
side of the cell in which nuclei were observed on the side of
the cell opposite to the spindle (Fig. 8E-H). These nuclei were
smaller and more brightly stained than normal nuclei and
appeared to have an intact nuclear membrane. Small amounts
of DNA staining material were seen in the spindle (Fig. 8G),
but it is unclear whether this DNA represented the chromo-
somes of micronuclei and/or whether these cells were in early
apoptosis. Few ‘mini-spindles’ were evident at 10 and 24 hours
post transfection, but the number increased at longer periods
of time post transfection (48 hours) to a point where few
normal prophase Mt arrays were observed in overexpressing
cells. This is consistent with the increase in the accumulation
of cells in G2 at 48 hours post transfection observed with FACS
analysis (Fig. 6D). The overexpression of wild-type cdc25B in
the cytoplasm appears to cause inappropriate activation of Mt
nucleation without the normally synchronised events of the
nucleus, resulting in the formation of abnormal ‘mini-spindles’
in the cytoplasm. 
G2/M arrest in cells overexpresssing wild-type or
mutant cdc25C is not due to an effect on prophase
microtubule nucleation
Immunofluorescent staining of cells transfected with wild-type
or mutant cdc25C showed that in most cells the overexpressed
protein was predominantly localised to the cytoplasm (Fig. 9A
and C) in contrast to the nuclear site of normally expressed
cdc25C (Fig. 5B). A small number of cells also had increased
staining in the nucleus, presumably due to the translocation of
the cdc25C to the nuclei in late prophase as reported previously
for the human cdc25C overexpressed in BHK cells (Heald et
al., 1993). No abnormal ‘mini-spindles’, such as were seen
with overexpression of wild-type cdc25B, were observed in
cells transfected with wild-type cdc25C, despite the fact that
the overexpressed wild-type cdc25C localised in the cytoplasm
(Fig. 9B). Also the percentage of cdc25C overexpressing cells
showing prophase Mt nucleation at centrosomal foci was the
same as the overall rate of transfection, indicating that wild-
type cdc25C overexpression has no effect on prophase Mt
nucleation (Table 3). 
Cells overexpressing mutant cdc25C also displayed normal
prophase Mt nucleation (Fig. 9D), and the percentage of nucle-
ating cells overexpressing mutant cdc25C in the cytoplasm was
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Fig. 8. Overexpression of mutant cdc25B in HeLa
cells results in a dominant negative effect on
prophase Mt nucleation. Coverslip cultures of HeLa
cells transfected with mutant cdc25B (CR/SK)
(A-D) or (C/S) (inserts) in a pUCSRa vector were
stained 48 hours post transfection using N-terminal
cdc25B (A,C) and a -tubulin (B,D) antibodies. Cells
with a lower level of overexpressed mutant cdc25B,
displaying predominantly staining in the cytoplasm
(e.g. A; C lower cell and insert) displayed different
levels of focussed Mt nucleation (Mt; B,D) which
were classified as follows: 0, an interphase basket-
like arrangement of Mt (B); +/-, intermediate Mt
arrangement i.e. Mt gathering presumably at the
centrosome but with no focus (D, arrowheads). The
heavily overexpressing cell with strong intranuclear
staining likewise diplayed bright Mt staining with a
± Mt arrangement. (E-H) ‘Mini-spindles’ are shown
in the cytoplasm of a cell with cytoplasmically
overexpressed (OP) wild-type cdc25B. Staining for
cdc25B (E), a -tubulin (F) and Hoechst 33342 for
DNA (G) show that the nuclear membrane appears
intact, although some Hoechst staining material is
apparent in the kinetochore attachment region (G),
and double staining for both Mt and DNA (H)
shows that the ‘mini-spindle’ has clearly formed in
the cytoplasm of the transfected cell. An
untransfected cell with the less intensely stained Mt
and DNA of an interphase cell is adjacent to the
transfected cell. at least as high as the overall rate of transfection (Table 3).
Clearly, the dominant negative effect on prophase Mt nucle-
ation which is observed with overexpression of mutant cdc25B
is due to specific blocking of endogenous cdc25B function,
while the overexpression of mutant cdc25C must inhibit
distinct, cdc25C catalysed G2/M functions. 
DISCUSSION
One of the striking aspects of cdc25B is its expression pattern,
notably its rapid accumulation at prophase and turnover upon
the completion of mitosis. This is in contrast to the cdc25C
isoform which is present at constant levels throughout the
HeLa cell cycle even though its primary function is at mitosis.
Likewise cdc25A, which has a G1/S function, is also constant
throughout the HeLa cell cycle (Hoffmann et al., 1994).
Although cdc25B is the only cdc25 isoform regulated at the
level of protein expression in HeLa cells, cdc25A protein
levels oscillate through the cell cycle in untransformed rat
fibroblasts (Jinno et al., 1994) and the single S. pombe cdc25is also regulated at the protein level (Moreno et al., 1990;
Docummun et al., 1990). In both these cases, the expression of
the respective cdc25 protein corresponds to the point in the cell
cycle which is regulated by these proteins. The constant
expression of cdc25A and cdc25C isoforms possibly confers a
growth advantage, facilitating the continuous cycling of HeLa
cells, but unregulated expression of cdc25B is detrimental to
cell growth, as we have observed with overexpression of wild-
type cdc25B. 
We have found that the increased expression of cdc25B at
prophase resulted in its accumulation in the perinuclear region
and cytoplasm prior to nuclear envelope breakdown. This
increased cytoplasmic expression correlated with the conver-
sion of the interphase centrosome to a prophase MTOC. The
overexpression of catalytically inactive mutants of cdc25B
produced an effective G2/M delay, evidence for a G2/M
function for cdc25B. The lack of prophase Mt nucleation in the
mutant overexpressing cells, even in those with low levels of
overexpression and which displayed predominantly cytoplas-
mic accumulation of cdc25B, suggests that the cytoplasmically
localised mutants blocked this late G2 cytoplasmic event. The
1091cdc25B regulates spindle formationoverexpression of mutant cdc25C also produced a G2/M delay,
but with much slower onset than that seen with mutant cdc25B
overexpression and without any detectable effect on the
prophase MTOC activity. The delayed effect of mutant cdc25C
overexpression may be due to a higher endogenous level of
cdc25C compared to cdc25B expressed in HeLa cells requiring
much higher levels of mutant protein expression to produce an
effect, or possibly could be due to the unexpected cytoplasmic
localisation of the overexpressed cdc25C. 
Further evidence for a role for cdc25B in the regulation of
Mt nucleation and dynamics comes from the unexpected and
striking results produced with the overexpression of the wild-
type cdc25B. FACS analysis indicated that overexpression of
wild-type cdc25B produced an accumulation of G2/M phase
cells, albeit at a much slower rate than that observed for the
catalytically inactive mutants, and some disturbance of S
phase. Overexpression of wild-type cdc25C did not similarly
affect the cell cycle, with only a small increase in the G2/M
population observed. This in itself was unexpected, as over-
expression of cdc25 in fission yeast produces the wee
phenotype due to the shortening of G2 (Russell and Nurse,
1986) rather than the small delay observed here. Most remark-
able was the appearance of ‘mini-spindles’ in cells overex-
pressing wild-type cdc25B in the cytoplasm. These cells had
sharply delineated nuclei which appeared to have intact nuclearFig. 9. Transfection of wild type or mutant cdc25C into HeLa cells
results in cytoplasmic overexpression which does not affect prophase
Mt nucleation. Coverslip cultures of HeLa cells transiently
transfected with wild type or mutant cdc25C in the pUCSRa vector
were examined by indirect immunofluorescence using cdc25C and
a -tubulin (Mt) antibodies. Transfected cells overexpressed wild type
or mutant cdc25C in the cytoplasm (A and C). Normal prophase Mt
nucleation was observed in those cells which were overexpressing
either wild type or mutant cdc25C (B and D). Bar, 10 m m. membranes and were brightly stained with Hoechst 33342
perhaps suggestive of early apoptosis (Sun et al., 1992; Cohen
et al., 1993). The inappropriate cdc25B activity in the
cytoplasm may cause the premature activation of Mt nucleation
at the centrosome and aberrant spindle formation, but without
normal chromosome condensation. This appeared to be an irre-
versible effect, witnessed by the slow accumulation of the
G2/M population seen in the FACS analysis. The potentially
lethal phenotype resulting from the wild-type overexpression
could explain why the expression of cdc25B is normally so
tightly regulated. Similar ‘mini-spindles’ have been reported
in BHK cells co-transfected with cdc25C and cyclin B1, but
were not seen with transfection of cdc25C or cyclin B1 sepa-
rately (Heald et al., 1993). This supports our findings that
cdc25C overexpression did not effect Mt dynamic or spindle
formation, but indicates that co-transfection of a cyclin may
compromise this specificity. These observations, together withFig. 10. A prophase cell stained for cyclin B1 (A), a -tubulin (B) and
DNA with Hoechst 33342 (C) is shown. The nuclear accumulation of
cyclin B1 is clearly evident and the centrosomal localisation of
cyclin B1 can be seen as the two brightly stained dots diagonally
opposed across the horizonal axis of the nucleus. Cyclin B1
associated with the spindle Mt can also been discerned. The nuclear
membrane is still intact, and chromatin condensation has not begun,
with the nucleoli still visible as negatively staining areas within the
nucleus (C). Bar, 8 m m.
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strong evidence that the dominant negative effect produced by
cdc25B mutants is due to the specific inhibition of the endoge-
nous cdc25B activity, and that cdc25B functions at prophase
to regulate the conversion of the interphase centrosome to a
prophase MTOC and the change in Mt dynamics. However,
the fact that cdc25B does localise to the nucleus in heavily
overexpressing cells points to a mechanism for cdc25B to
accumulate in that compartment, so that an additional, nuclear
function for cdc25B cannot be dismissed. 
The normal prophase expression of cdc25B was restricted
to the soluble cytoplasmic fraction; no evidence of cdc25B
associating with either the Mt network or centrosomes was
found by either indirect immunofluorescence or subcellular
fractionation, suggesting that cdc25B regulates the changes in
Mt nucleation and dynamics via an indirect mechanism. This
is probably through its ability to dephosphorylate and activate
cdc2/cyclin B (Sebastian et al., 1993), and this kinase complex
is probably a major substrate in vivo. Evidence from a number
of laboratories has pointed to the active cdc2/cyclin B having
a major role in producing the prophase changes in Mt dynamics
and mitotic spindle formation (Verde et al., 1992; Masuda et
al., 1992; Ohta et al., 1993), and cyclin B1 has been shown to
associate with Mt fibres and centrosomes (Fig. 10A; Pines and
Hunter, 1991; Bailly et al., 1992). 
What is the rationale for separate isoforms of cdc25 regu-
lating the same cell cycle transition? In fission yeast, cdc2 and
its cyclin partner cdc13 are localised strictly to the nucleus
(Alpha et al., 1990). The mitotic spindle itself forms within the
nucleus and thus the single cdc25 is sufficient for the regula-
tion of nuclear rearrangements and spindle formation at mitosis
in S. pombe. The diversity of cellular structure and shape
apparent in mammalian cells in comparison to yeast has neces-
sitated the development of an extensive cytoskeletal network
underpinned by Mt fibres. The prophase rearrangement of the
interphase Mt network produces the mitotic scaffold to catch
condensed chromosomes by their kinetochores after nuclear
envelope breakdown, allowing the metaphase plate to assemble
efficiently and quickly. Thus the formation of a perinuclear
array of prophase Mt would be expected to occur earlier than
nuclear envelope breakdown as is clearly evident in a typical
mid-prophase cell such as that seen in Fig. 10B and C. The
economy of reassembling the tubulin component of this cyto-
plasmic framework to form a cytoplasmic (rather than intranu-
clear) mitotic spindle gives meaning to the evolution of
separate cytoplasmic and nuclear isoforms of cdc25. From our
data, we propose that cdc25B is responsible for the activation
of the cytoplasmic (and centrosomal) cdc2/cyclin B at
prophase, and that one of the consequences is the change in Mt
dynamics and spindle formation. Cdc25C does not appear to
effect this cytoplasmic function, and we would propose that it
activates the large nuclear pool of cdc2/cyclin B, suggested by
its localisation to that compartment. 
Centrosomal Mt nucleation and prophase spindle formation
occurs prior to nuclear envelope breakdown, when cdc25C is
still intranuclear (Fig. 5B). At prophase, the majority of the
cdc2/cyclin B1 complex has been translocated to the nucleus,
but small pools remain in the cytoplasm and associated with
the centrosomes and Mt arrays (Fig. 10A). The nuclear pool of
cdc2/cyclin B1 is presumably not yet active, evidenced by the
absence of events initiated by cdc2/cyclin B activity such aschromosome condensation or nucleolar disintegration (Fig.
10C; Lamb et al., 1990; Peter et al., 1990; Belenguer et al.,
1990), whereas the cytoplasmic (and Mt and centrosomal asso-
ciated) cyclin B1 complex is presumably active, as evidenced
by the increased Mt nucleation at the centrosomes and change
in Mt dynamics (Fig. 10B). Thus, the presence of a preformed
mitotic spindle for rapid capture of condensed chromosomes
after nuclear envelope breakdown requires that the cytoplas-
mic mitotic events precede the nuclear rearrangements in a
strictly ordered manner. Two further observations support the
existence of a sequential mechanism. First, the cytoplasmic
overexpression of cdc25B mutants not only inhibited the
formation of the mitotic spindle in cells showing prophase sep-
aration of centrosomes, but also blocked chromosomal con-
densation and nucleolar disintegration (Fig. 8A and C). We
failed to find any cdc25B mutant expressing cells with
condensed chromatin but lacking some form of a mitotic
spindle. Second, the higher percentage of cells displaying both
prophase Mt nucleation and uncondensed DNA in the mutant
cdc25C overexpressing group compared to the untransfected
cells (Table 3) points to a block in a mitotic event subsequent
to spindle formation, presumably the nuclear rearrangements,
with the resultant accumulation of cells with prophase spindles. 
The data presented here provide evidence that the activation
of the mitotic kinase, presumably cdc2/cyclin B, in separate
cellular compartments is controlled by distinct isoforms of
cdc25 phosphatase, and clarify a mechanism by which
essential cytoplasmic functions, such as prophase Mt nucle-
ation and spindle formation, can occur prior to nuclear
envelope breakdown. 
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